Phenomenex, Global Leader in Separation Sciences Technology, Announces Acquisition of Two Companies in Italy and Denmark
Both companies were exclusive distributors for chromatography products developed by Phenomenex. Terms of the acquisitions were not disclosed.
Phenomenex is a technology pioneer in research and manufacturing chromatography products used in the separation, analysis and purification of pharmaceuticals, biopharmaceuticals and a broad spectrum of chemicals. With projected '07 sales exceeding $110 million and 465 employees, privately held Phenomenex has offices in Canada, the U.K., Germany, Austria, France, Italy, Denmark, Australia and New Zealand, and also sells its products through a network of partners and distributors in 59 other countries.
"Phenomenex has had long, successful partnerships with these companies, so buying them represents a natural progression for us," says Fasha Mahjoor, founder and chief executive officer of Phenomenex. "They understand our focus on constant innovation and unyielding drive to maintain our position as the technology leader in chromatography. Both share with us a commitment to stay close to the customer. As members of the growing Phenomenex family, they will play an indispensable role in building a cohesive, unifying, worldwide brand presence."
Plans call for both companies to assume the Phenomenex corporate identity. In Italy, the company will be called Phenomenex S.R.L. In Denmark, the company will be known as Phenomenex ApS.
"Chemtek has collaborated closely with Phenomenex for more than 20 years," says Alberto Albieri, newly-appointed sales and marketing manager with Phenomenex S.R.L. and one of the founders and directors of Chemtek Analytica.
"As Phenomenex has emerged as the technology leader in chromatography consumables, we have worked hard doing our part to contribute to its success in Italy. This is a perfect time for our Italian customers, who range from pharmaceutical manufacturers to environmental, petrochemical and healthcare companies, to have direct access to all of the resources of Phenomenex."
Similar sentiments were offered by Else Togo, general manager of Phenomenex ApS.
"The pace of technology innovations in chromatography products is astounding today," says Togo. "We have had a long partnership with Phenomenex, and we know its commitment to new product development is second to none. With important customers in life sciences, chemical, biotech, and food and beverage, demand for Phenomenex's products in Denmark covers the spectrum of chromatography consumables. Providing our customers with a direct pipeline will give us a strong competitive edge."
The transition process is expected to be brief and seamless. There will be no layoffs or staff reductions. In fact, the teams of both organizations will remain and each anticipates announcing staff expansions sometime in the second quarter.
"Phenomenex has a reputation for leading its peers each year with double digit financial gains, and these strategic acquisitions position us favorably for future growth," says Bert G. Rietveld, director of business development for Phenomenex. "Being responsive to the needs of our customers in the European Union is critical to our success. That is why these acquisitions are investments in our future."
About Phenomenex, Inc.
Phenomenex, Inc., a global leader in separation sciences technology, is a privately held corporation headquartered in Torrance, California. Phenomenex is celebrating 25 years of innovation and achievement, marking its birth as a company driven by a constant focus to innovate.
Phenomenex develops, manufactures and distributes chromatography products for the separation, analysis and purification of pharmaceuticals, biopharmaceuticals and a broad spectrum of chemicals. It serves a broad base of customers worldwide involved in the life sciences, environmental, chemical and healthcare industries. With projected '07 sales exceeding $110 million and 465 employees, Phenomenex spans the globe with offices in Canada, the U.K., Germany, Austria, France, Italy, Denmark, Australia and New Zealand, and also sells its products through a network of partners and distributors in 59 other countries.
For more information, visit www.phenomenex.com.
Posted: April 2007